Definition of TCR recognition sites on Ld-tum- complexes

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The P911 mastocytoma variant induces tumor rejection mediated by Ld-restricted cytotoxic T lymphocytes (CTL).
• Previous studies identified T cell clones recognizing Ld-peptide complexes with restricted TCR usage.
• The natural tumor peptide (tum-) is a 13-mer, deviating from typical Ld-binding nonamer motifs.

Purpose of the Study:

• To define shorter, optimal peptide analogs of the 13-mer tum- peptide.
• To identify specific residues within the peptide critical for T cell receptor (TCR) recognition.
• To elucidate the molecular interactions between the peptide and TCR in the context of Ld presentation.

Main Methods:

• Synthesis and characterization of nonamer peptide derivatives of the tum- peptide.
• Binding assays to assess peptide-Ld interactions.
• Functional assays using CTL clones to evaluate peptide recognition.
• Alanine-scanning mutagenesis of the optimal nonamer to probe TCR contact residues.

Main Results:

• The nonamer peptide TQNHRALDL was identified as optimal for CTL recognition.
• Histidine and Arginine residues at positions 4 and 5 of the nonamer are critical for TCR interaction.
• These basic residues likely interact with acidic residues in the CDR3 region of specific TCRs.

Conclusions:

• The optimal nonamer peptide TQNHRALDL effectively sensitizes targets for CTL recognition.
• Specific basic residues within the tum- peptide are essential for TCR binding and activation.
• This work provides insights into the structural basis of TCR-peptide-MHC interactions in anti-tumor immunity.